Eli Lilly and Company (VIE:LLYC)
917.30
+43.40 (4.97%)
Last updated: Feb 4, 2026, 1:35 PM CET
Eli Lilly and Company Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 3,268 | 2,819 | 2,067 | 3,819 |
Short-Term Investments | - | 154.8 | 109.1 | 144.8 | 90.1 |
Trading Asset Securities | - | 10.3 | 113.8 | 230.5 | 4.8 |
Cash & Short-Term Investments | 9,914 | 3,434 | 3,042 | 2,442 | 3,913 |
Cash Growth | 188.73% | 12.89% | 24.53% | -37.59% | 6.30% |
Accounts Receivable | - | 11,006 | 9,091 | 6,896 | 6,673 |
Other Receivables | - | 1,923 | 2,002 | 1,406 | 1,440 |
Receivables | - | 12,929 | 11,093 | 8,302 | 8,113 |
Inventory | - | 7,589 | 5,773 | 4,310 | 3,886 |
Prepaid Expenses | - | 8,341 | 5,541 | 2,947 | 2,531 |
Other Current Assets | - | 447.9 | 279.1 | 33.9 | 9.9 |
Total Current Assets | - | 32,740 | 25,727 | 18,035 | 18,452 |
Property, Plant & Equipment | - | 18,153 | 13,938 | 10,144 | 8,985 |
Long-Term Investments | - | 3,267 | 3,407 | 3,201 | 3,405 |
Goodwill | - | 5,770 | 4,940 | 4,073 | 3,892 |
Other Intangible Assets | - | 6,166 | 6,907 | 7,207 | 7,692 |
Long-Term Deferred Tax Assets | - | 8,001 | 5,477 | 2,793 | 2,489 |
Other Long-Term Assets | - | 4,619 | 3,611 | 4,038 | 3,891 |
Total Assets | - | 78,715 | 64,006 | 49,490 | 48,806 |
Accounts Payable | - | 3,229 | 2,599 | 1,931 | 1,671 |
Accrued Expenses | - | 13,713 | 13,418 | 9,923 | 7,880 |
Short-Term Debt | - | 4,338 | 6,189 | 1,498 | - |
Current Portion of Long-Term Debt | - | 781.5 | 745.9 | 3.1 | 1,540 |
Current Portion of Leases | - | 175.7 | 156.3 | - | - |
Current Income Taxes Payable | - | - | - | - | 126.9 |
Other Current Liabilities | - | 6,140 | 4,185 | 3,784 | 3,836 |
Total Current Liabilities | - | 28,377 | 27,293 | 17,138 | 15,053 |
Long-Term Debt | - | 28,645 | 18,425 | 14,872 | 15,387 |
Long-Term Leases | - | 970.9 | 948.5 | - | - |
Pension & Post-Retirement Benefits | - | 1,301 | 1,439 | 1,305 | 1,954 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1,734 |
Other Long-Term Liabilities | - | 5,150 | 5,038 | 5,399 | 5,524 |
Total Liabilities | - | 64,443 | 53,143 | 38,714 | 39,651 |
Common Stock | - | 592.4 | 593.6 | 594.1 | 596.3 |
Additional Paid-In Capital | - | 7,439 | 7,250 | 6,921 | 6,833 |
Retained Earnings | - | 13,545 | 10,312 | 10,043 | 8,959 |
Treasury Stock | - | -49.5 | -44.2 | -50.5 | -52.7 |
Comprehensive Income & Other | - | -7,335 | -7,340 | -6,858 | -7,356 |
Total Common Equity | 23,793 | 14,192 | 10,772 | 10,650 | 8,979 |
Minority Interest | - | 79.5 | 91.8 | 125.6 | 175.6 |
Shareholders' Equity | 23,851 | 14,272 | 10,864 | 10,775 | 9,155 |
Total Liabilities & Equity | - | 78,715 | 64,006 | 49,490 | 48,806 |
Total Debt | 42,578 | 34,911 | 26,465 | 16,373 | 16,927 |
Net Cash (Debt) | -32,344 | -30,992 | -22,712 | -13,247 | -11,733 |
Net Cash Per Share | -35.97 | -34.28 | -25.14 | -14.64 | -12.87 |
Filing Date Shares Outstanding | 895.38 | 898.17 | 900.16 | 900.3 | 902.35 |
Total Common Shares Outstanding | 895.84 | 897.54 | 899.38 | 900.18 | 903.65 |
Working Capital | - | 4,363 | -1,566 | 896.3 | 3,400 |
Book Value Per Share | 26.56 | 15.81 | 11.98 | 11.83 | 9.94 |
Tangible Book Value | 11,449 | 2,256 | -1,074 | -629.8 | -2,605 |
Tangible Book Value Per Share | 12.78 | 2.51 | -1.19 | -0.70 | -2.88 |
Land | - | 382 | 319.8 | 256.6 | 258.7 |
Buildings | - | 8,807 | 8,280 | 7,916 | 7,588 |
Machinery | - | 11,458 | 10,329 | 9,406 | 8,937 |
Construction In Progress | - | 8,245 | 5,084 | 2,799 | 2,178 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.